CHAI works on both the supply and demand sides of the market to lower costs and increase the availability of the best health products for low- and middle-income countries. Working with the public and private sector, we help shape markets and realize savings for drugs, devices, and diagnostics in all areas of our work. We help governments maximize the impact of their limited funding by negotiating agreements with the private sector to make their health products more affordable. In parallel, we are on the ground to help countries set up treatment protocols – which medications should be used, which diagnostic tests should be done – as well as laboratory systems to do the testing, supply systems to deliver medicine and care, and training for healthcare workers. CHAI works with ministries of health to measure the impact of these programs and respond as needed – all with the goal of working ourselves out of a job. CHAI’s Global Markets and Lab Services Teams help drive our market-shaping work across programs and countries.
The Global Markets Team helps global life science companies understand what products are needed in low- and middle-income countries, what prices are sustainable, and how to navigate complex regulatory, market introduction, and procurement systems. The team helps companies that make the world’s most valuable and essential health care products find practical ways to get their products to the tens of millions of people who need them through licensing agreements, volume guarantees, and product development agreements. Together with partners, CHAI has negotiated over 120 agreements that have increased and expanded patients’ access to treatment and critical public health commodities, such as best-in-class HIV regimens and contraceptive implants.
The Lab Services team supports countries to improve laboratories and testing infrastructure and introduce and scale up new technologies, with a focus on products used to diagnose and monitor HIV, TB, and hepatitis. The team is working to address critical health care gaps, such as supporting more targeted HIV testing and the use of better quality rapid diagnostic tests, to increase diagnosis of HIV for adults and children of which only 50 percent currently know their status. Since 2006, Lab Services has scaled up access to early infant diagnosis for millions of babies exposed to HIV and introduced point-of-care technologies that deliver same-day results, so that families do not need to wait weeks or even months before starting treatment.
How CHAI helps lower prices and increase access to life-saving health products
May 10, 2019
HIV Mid-Year Market Memo 2019
Introducing the third edition of CHAI’s HIV Mid-Year Market Memo, a brief that that covers the latest trends in the HIV space in low- and middle-income countries since the publication of CHAI’s annual HIV Market Report in September 2018. Read the HIV Mid-Year Market Memo here. Read the 2018 HIV Market Report.Read More
July 25, 2018
Breakthrough agreement will reduce costs and increase access to diagnostic technology for millions in low- and middle-income countries
Amsterdam – A breakthrough pricing agreement will significantly reduce the cost of diagnostic testing for HIV/AIDS, hepatitis and cervical cancer for millions of people in low- and middle-income countries. Diagnostic testing improves patient care, helps prevent the spread of disease, and reduces healthcare spending. The new agreement, announced today at the 2018 International AIDS Conference,...Read More
May 26, 2020
CHAI’s first-ever HCV Market Report provides new insights to guide elimination efforts
The report provides an overview of the supplier landscape for WHO recommended drugs and diagnostics, outlines supply and pricing trends, highlights global benchmark prices, and suggests ways in which low- and middle-income countries can access testing and treatment at more affordable prices.Read More